ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04110	Cell cycle	25/296	145/7206	7.24873303552e-10
ko03008	Ribosome biogenesis in eukaryotes	18/296	79/7206	1.88497673591e-09
ko05217	Basal cell carcinoma	16/296	68/7206	9.32673463851e-09
ko04111	Cell cycle - yeast	17/296	90/7206	1.05349668721e-07
ko03410	Base excision repair	11/296	38/7206	2.08335047152e-07
ko04340	Hedgehog signaling pathway	13/296	58/7206	4.34919846921e-07
ko04550	Signaling pathways regulating pluripotency of stem cells	21/296	165/7206	3.38941466681e-06
ko03030	DNA replication	9/296	38/7206	1.67837723941e-05
ko03040	Spliceosome	18/296	145/7206	2.43053703416e-05
ko00240	Pyrimidine metabolism	14/296	110/7206	0.000149674470771
ko04390	Hippo signaling pathway	19/296	188/7206	0.000243759784564
ko04020	Calcium signaling pathway	1/296	265/7206	0.000364760399441
ko04113	Meiosis - yeast	10/296	70/7206	0.000522327309397
ko04144	Endocytosis	3/296	342/7206	0.000648809486834
ko05224	Breast cancer	17/296	174/7206	0.000760235723706
ko04330	Notch signaling pathway	9/296	62/7206	0.000878331039378
ko04310	Wnt signaling pathway	17/296	181/7206	0.00164114668955
ko04921	Oxytocin signaling pathway	1/296	209/7206	0.00231693545791
ko05166	HTLV-I infection	23/296	292/7206	0.00232692893073
ko04013	MAPK signaling pathway - fly	12/296	115/7206	0.0025757082633
ko04218	Cellular senescence	16/296	177/7206	0.00297801312892
ko04612	Antigen processing and presentation	9/296	77/7206	0.00408151298878
ko05205	Proteoglycans in cancer	21/296	271/7206	0.00449369201226
ko05200	Pathways in cancer	33/296	492/7206	0.00451253245266
ko04072	Phospholipase D signaling pathway	1/296	197/7206	0.0051690576844
ko04950	Maturity onset diabetes of the young	5/296	29/7206	0.00596133611977
ko05206	MicroRNAs in cancer	15/296	177/7206	0.00656590998114
ko04932	Non-alcoholic fatty liver disease (NAFLD)	1/296	182/7206	0.00716809231411
ko04723	Retrograde endocannabinoid signaling	1/296	175/7206	0.0105702937641
ko04022	cGMP-PKG signaling pathway	2/296	216/7206	0.0130787667261
ko05202	Transcriptional misregulation in cancer	15/296	188/7206	0.0134448834848
ko04062	Chemokine signaling pathway	2/296	201/7206	0.0178012840167
ko04360	Axon guidance	17/296	233/7206	0.0182498497186
ko04270	Vascular smooth muscle contraction	1/296	154/7206	0.0218478830945
ko04621	NOD-like receptor signaling pathway	1/296	157/7206	0.0223879354017
ko04060	Cytokine-cytokine receptor interaction	2/296	191/7206	0.0250402678947
ko05222	Small cell lung cancer	8/296	89/7206	0.0292561061255
ko05418	Fluid shear stress and atherosclerosis	13/296	173/7206	0.0310301908564
ko05016	Huntington's disease	3/296	215/7206	0.0358587149303
ko04024	cAMP signaling pathway	5/296	279/7206	0.0446690316358
ko04261	Adrenergic signaling in cardiomyocytes	3/296	205/7206	0.0490674038183
ko04910	Insulin signaling pathway	2/296	172/7206	0.0492326153344